Chalmers (TiPS vol. 17, pp. 166-172 Apr. 1996).* |
DeLaGarza VW., Am Fam Physician, Oct. 1, 2003, vol. 68, No. 7, pp. 1365-1372.* |
Gruol, D.L., et al; Physiological and Pathological Roles of Interleukin-6 in the Central Nervous System, Molecular Neurobiology, vol. 15, 1997, pp 307-339. |
Holden, R.J., et al; Interleukin 1,β: A Common Cause of Alzheimer's Disease and Diabetes Mellitus; Medical Hypotheses (1995) 45, pp. 559-571. |
Facts: About Nonsteroidal Anti-Inflammatory Drugs—Fact Sheet provided by the Alzheimer's Association 06/03. |
Harada, A; et al; Interleukin 8 as a novel target for intervention therapy in acute inflammatory diseases; Molecular Medicine Today, Nov. 1996 pp 482-489. |
Kostulas, N. et al Ischemic Stroke is Associated with a Systemic Increase of Blood Mononuclear Cells Expressing Interleukin-8 mRNA, Division of Neurology, Karolinska Institute, Huddinge University Hospital. |
Hawley's Condensed Chemical Dictionary Thirteenth Edition revised by Richard J. Lewis Sr., p. 21. |